Medasense’s NOL monitoring technology found to reduce opioid-consumption
Medical devices developer Medasense Biometrics has announced positive results from clinical outcome studies using the NOL monitoring technology…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Nov 18
Medical devices developer Medasense Biometrics has announced positive results from clinical outcome studies using the NOL monitoring technology…
31 Oct 18
Advanced medical technologies firm Covalon Technologies has completed the integration of AquaGuard into its operations.
29 Oct 18
Medical research, discovery and development company Humacyte has started a phase II vascular trauma clinical trial of Humacyl…
29 Oct 18
British medical technology company ConvaTec Group has received 510(k) clearance from the US Food and Drug Administration (FDA)…
25 Oct 18
Avita Medical has commenced a randomized and controlled clinical study of the Recell autologous cell harvesting device (Recell…
17 Oct 18
Regenerative medicine company ACell and healthcare products provider Southmedic have launched Cytal Wound Matrix and MicroMatrix devices in…
09 Oct 18
Tissue Analytics, a developer of artificial intelligence-powered software solutions for several therapy areas, has launched a 3D wound…
03 Oct 18
BioLargo, a developer of sustainable science and technologies, has agreed to acquire stem cell therapy technology known as…
03 Oct 18
Scapa Healthcare, an outsource partner of skin friendly turn-key solutions, has acquired Systagenix manufacturing facility located in Gargrave,…
01 Oct 18
EO2 Concepts said results from two studies demonstrated that continuous diffusion of oxygen (CDO) therapy with the EO2…